Durable Response to Combined Dabrafenib and Trametinib in a Patient With BRAF K601E Mutation-Positive Lung Adenocarcinoma: A Case Report
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference7 articles.
1. Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial;Planchard;Lancet Oncol,2017
2. Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations;Dankner;Oncogene,2018
3. Targeted therapy in BRAF p.K601E–driven NSCLC: case report and literature review;Saalfeld;JCO Precis Oncol,2020
4. Targeted therapy in advanced melanoma with rare BRAF mutations;Menzer;J Clin Oncol,2019
5. Dabrafenib plus trametinib in BRAF K601E-mutant melanoma;Rogiers;Br J Dermatol,2019
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Challenges in the treatment of BRAF K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib;Frontiers in Oncology;2024-07-08
2. SH003 Enhances the Anti-cancer Effects of Dabrafenib on Lung Cancer HarboringBRAFG469A Mutation by Inhibiting the MAPK Signaling Pathway;Anticancer Research;2024-04-27
3. Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non–Small Cell Lung Cancer;Journal of the National Comprehensive Cancer Network;2024-04
4. Outcomes of non-small cell lung cancer patients with non-V600E BRAF mutations: a series of case reports and literature review;Frontiers in Oncology;2024-03-27
5. BRAF/MEK-targeted therapy in BRAF ex15 p.T599dup mutation-driven NSCLC: a case report;Journal of Cancer Research and Clinical Oncology;2024-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3